Blood Cancers and Blood Disorders Team

Dr. Brian Druker (left) and Dr. Gordon Mills talking at the OHSU Knight Cancer Research building.
Research is a driving force in our patient care. Dr. Brian Druker (left), Knight Cancer Institute CEO, and Dr. Gordon Mills are internationally recognized cancer scientists. Mills, who also holds a Ph.D., is director of precision oncology.

Your care team at the OHSU Knight Cancer Institute will include world leaders in treating blood disorders and blood cancers. Our CEO, Dr. Brian Druker, played a central role in developing  Gleevec, a lifesaving medication for chronic myeloid leukemia. We are also helping lead Beat AML, a national effort to find new treatments for acute myeloid leukemia.

We offer you:

  • Doctors who are also part of OHSU’s Center for Hematologic Malignancies, with detailed expertise in even rare blood diseases.
  • Team-based care, with specialists meeting often to discuss each patient and develop the most effective treatment options.
  • Deep specialization, helping us precisely match treatments to your specific blood cancer or disorder.
  • An emphasis on research that translates laboratory findings into patient care.
  • Access to clinical trials, giving our patients the chance to try promising new therapies.

Blood cancers and blood disorders

Bone marrow/stem cell transplants

Meet our immunotherapy and cell transplant therapy team. Our team has done more than 4,500 bone marrow/stem cell transplants in adults in children, putting us among the nation's top 20 transplant centers.

For patients

Call 503-494-7999 to:

  • Request an appointment
  • Seek a second opinion
  • Ask questions


Knight Cancer Institute, South Waterfront

Center for Health & Healing, Building 2
3485 S. Bond Avenue
Portland, OR 97239

Free parking for patients and visitors

Refer a patient

Cancer clinical trials

Clinical trials allow patients to try a new test or treatment.